NDUFS8 and hepatocellular carcinoma: in vivo studies, intratumoral injection of an adeno-associated virus carrying NDUFS8-targeting shRNA (AAV-shNDUFS8) significantly inhibited the growth of subcutaneous HCC xenografts in nude mice, further supporting the therapeutic potential of targeting NDUFS8.